Literature DB >> 22992339

Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients.

Tomonori Tanaka1, Kyoko Otani, Ryoko Egashira, Yukio Kashima, Hiroyuki Taniguchi, Yasuhiro Kondoh, Kensuke Kataoka, Akira Shiraki, Yasuhiko Kitasato, Kevin O Leslie, Junya Fukuoka.   

Abstract

Myeloperoxidase anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) is a well known marker for small vessel vasculitis. Recent reports have demonstrated that interstitial pneumonia (IP) may rarely be associated with serum MPO-ANCA. Yet, little is known about the histological features. We reviewed surgical lung biopsy from nine patients with IP of uncertain etiology with serum MPO-ANCA. There was a male predominance (6:3) with a median age of 62.1. Histologically, eight patients presented with a usual interstitial pneumonia (UIP) pattern of pulmonary fibrosis, frequently accompanied by areas of nonspecific interstitial pneumonia (NSIP) pattern. One patient showed diffuse alveolar damage (DAD), and two patients showed mixture of UIP and DAD reflecting acute exacerbation of UIP. Microscopic honeycomb cysts were common, but fibroblastic foci were inconspicuous. The most frequent additional findings were small airway disease (9/9), and lymphoid follicles (7/9). Neither capillaritis nor vasculitis was seen in any of our cases. Three patients had microscopic hematuria, but none progressed to microscopic polyangiitis during the follow up. Mortality rate was 44% (median follow up 39.1 months). IP associated with MPO-ANCA showed characteristic histology dominated by UIP pattern. Vasculitis was not identified in our cohort, but small airways disease and lymphoid follicles were present in most cases. IP associated with MPO-ANCA may be a histologically distinctive disease from idiopathic pulmonary fibrosis. Mortality was relatively high and life threatening acute exacerbation may occur.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992339     DOI: 10.1016/j.rmed.2012.08.024

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  16 in total

Review 1.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

2.  Microscopic polyangiitis associated with pulmonary fibrosis.

Authors:  Marcelo Fernandez Casares; Alejandra Gonzalez; Mariano Fielli; Flavia Caputo; Yanina Bottinelli; Marcelo Zamboni
Journal:  Clin Rheumatol       Date:  2014-05-27       Impact factor: 2.980

3.  Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Gabrielle Y Liu; Iazsmin Bauer Ventura; Natalia Achtar-Zadeh; Brett M Elicker; Kirk D Jones; Paul J Wolters; Harold R Collard; Ayodeji Adegunsoye; Mary E Strek; Brett Ley
Journal:  Chest       Date:  2019-06-07       Impact factor: 9.410

4.  Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.

Authors:  Hironao Hozumi; Noriyuki Enomoto; Yoshiyuki Oyama; Masato Kono; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Takafumi Suda
Journal:  Lung       Date:  2016-02-12       Impact factor: 2.584

5.  Pleuroparenchymal fibroelastosis with positive MPO-ANCA diagnosed with a CT-guided percutaneous needle biopsy.

Authors:  Hideaki Yamakawa; Tsuneyuki Oda; Tomohisa Baba; Takashi Ogura
Journal:  BMJ Case Rep       Date:  2018-02-24

6.  Pathological and radiological correlation in an autopsy case of combined pulmonary fibrosis and emphysema.

Authors:  Hiroki Karata; Tomonori Tanaka; Ryoko Egashira; Kazuhiro Tabata; Kyoko Otani; Ryuji Hayashi; Takashi Hori; Junya Fukuoka
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-08

7.  Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis.

Authors:  Naho Kagiyama; Noboru Takayanagi; Tetsu Kanauchi; Takashi Ishiguro; Tsutomu Yanagisawa; Yutaka Sugita
Journal:  BMJ Open Respir Res       Date:  2015-01-09

8.  Microscopic polyangiitis preceded by combined pulmonary fibrosis and emphysema.

Authors:  Kyoko Gocho; Keishi Sugino; Keita Sato; Chikako Hasegawa; Toshimasa Uekusa; Sakae Homma
Journal:  Respir Med Case Rep       Date:  2015-06-04

9.  Organizing pneumonia associated with myeloperoxidase anti-neutrophil cytoplasmic antibody.

Authors:  Shiro Imokawa; Masahiro Uehara; Tomohiro Uto; Jun Sato; Takafumi Suda
Journal:  Respirol Case Rep       Date:  2015-09-10

10.  Combined pulmonary fibrosis and emphysema with myeloperoxidase-antineutrophil cytoplasmic antibody positivity that resolved upon smoking cessation.

Authors:  Masahiro Nemoto; Satoshi Noma; Ayumu Otsuki; Kei Nakashima; Koichi Honma; Takeshi Johkoh; Junya Fukuoka; Masahiro Aoshima
Journal:  Respir Med Case Rep       Date:  2018-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.